AP-10 Blood Glucose Monitoring System - Taiwan Registration 1fa0e5b8c20ecd6ec630d8157c24fc1e
Access comprehensive regulatory information for AP-10 Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1fa0e5b8c20ecd6ec630d8157c24fc1e and manufactured by LEISON BIOTECH CO., LTD.. The authorized representative in Taiwan is LEISON BIOTECH CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
1fa0e5b8c20ecd6ec630d8157c24fc1e
Ministry of Health Medical Device Manufacturing No. 005994
Product Details
This product is intended for self-quantitative detection of fingertip microvascular whole blood and professional quantitative detection of glucose in venous whole blood blood.
A Clinical chemistry and clinical toxicology
A1345 Glucose Test System
Produced in Taiwan, China
Dates and Status
Aug 02, 2018
Aug 02, 2028

